Gold Flora Corporation Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2024-09-30..
- Stock-based compensation / revenue · 12 months: Value 0.43%; Formula and calculation Share-based compensation / revenue. Period ending 2024-09-30..
- Interest coverage · 12 months: Value -2.91×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2024-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2024-09-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.43% | Share-based compensation / revenue. Period ending 2024-09-30. $539.00K ÷ $124.81M × 100 ≈ 0.43% |
| Interest coverage · 12 months | -2.91× | Operating income ÷ reported interest expense. $-50.43M ÷ $17.36M ≈ -2.91× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 124.81M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 539.00K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -50.43M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 17.36M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | (m) | $124.81M | $539.00K | $-50.43M | $17.36M | (m) | 0.43% | -2.91× | Reported |
| 2024-06-30 | (m) | $124.15M | $921.00K | $-55.21M | $19.14M | (m) | 0.74% | -2.88× | Reported |
| 2024-03-31 | (m) | $107.47M | $877.00K | $-50.80M | $19.26M | (m) | 0.82% | -2.64× | Reported |
| 2023-12-31 | (m) | $90.96M | $740.00K | $-46.74M | $19.64M | (m) | 0.81% | -2.38× | Reported |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $58.87M | $-1.79M | $30.48M | $24.16M | (m) | -3.05% | 1.26× | Reported |
| 2022-12-31 | (m) | $65.66M | $392.00K | $3.17M | $20.71M | (m) | 0.60% | 0.15× | Reported |
| 2022-09-30 | (m) | $88.21M | $-1.09M | $-64.89M | $16.54M | (m) | -1.23% | -3.92× | Reported |
| 2022-06-30 | (m) | $29.92M | $5.19M | $-625.71M | $5.07M | (m) | 17.34% | -123.39× | Reported |
| 2022-03-31 | (m) | $62.45M | (m) | $-652.12M | $5.23M | (m) | (m) | -124.64× | Reported |
| 2021-12-31 | $32.27K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | (m) | (m) | $-8.81M | $0.00 | (m) | (m) | (m) | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.